Claude P. Selitrennikoff

6.8k total citations · 1 hit paper
85 papers, 3.6k citations indexed

About

Claude P. Selitrennikoff is a scholar working on Molecular Biology, Plant Science and Biotechnology. According to data from OpenAlex, Claude P. Selitrennikoff has authored 85 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 36 papers in Plant Science and 27 papers in Biotechnology. Recurrent topics in Claude P. Selitrennikoff's work include Polysaccharides and Plant Cell Walls (14 papers), Enzyme Production and Characterization (14 papers) and Antifungal resistance and susceptibility (13 papers). Claude P. Selitrennikoff is often cited by papers focused on Polysaccharides and Plant Cell Walls (14 papers), Enzyme Production and Characterization (14 papers) and Antifungal resistance and susceptibility (13 papers). Claude P. Selitrennikoff collaborates with scholars based in United States, France and Morocco. Claude P. Selitrennikoff's co-authors include Walden K. Roberts, David A. Stevens, David Quigley, Carol S. Enderlin, Marc Schumacher, Lisa A. Alex, Alison J. Vigers, Christopher Korch, Michel Legrand and Bernard Fritig and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Applied and Environmental Microbiology and Genetics.

In The Last Decade

Claude P. Selitrennikoff

84 papers receiving 3.4k citations

Hit Papers

Plant and Bacterial Chitinases Differ in Antifungal Activity 1988 2026 2000 2013 1988 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claude P. Selitrennikoff United States 29 2.0k 1.8k 697 629 502 85 3.6k
Rafael Sentandreu Spain 38 1.6k 0.8× 2.5k 1.4× 396 0.6× 1.7k 2.8× 858 1.7× 158 4.4k
E Cabib United States 39 2.4k 1.2× 3.7k 2.0× 705 1.0× 497 0.8× 269 0.5× 53 5.2k
Thorsten Heinekamp Germany 40 1.6k 0.8× 2.3k 1.2× 273 0.4× 1.6k 2.5× 747 1.5× 83 4.5k
J. L. Richard United States 36 4.1k 2.0× 831 0.5× 270 0.4× 198 0.3× 159 0.3× 125 5.1k
Wilhelm Schäfer Germany 41 3.3k 1.6× 1.6k 0.9× 204 0.3× 1.3k 2.1× 1.0k 2.1× 80 5.4k
Claude Gaillardin France 41 817 0.4× 4.1k 2.3× 525 0.8× 774 1.2× 582 1.2× 87 5.2k
Philip Youngman United States 39 698 0.3× 3.2k 1.8× 1.1k 1.5× 439 0.7× 158 0.3× 58 5.3k
Erwin Märtlbauer Germany 39 1.2k 0.6× 3.0k 1.6× 1.1k 1.5× 503 0.8× 42 0.1× 171 5.1k
John E. Linz United States 42 3.6k 1.8× 2.5k 1.4× 423 0.6× 355 0.6× 70 0.1× 110 5.3k
Ping He United States 57 8.7k 4.3× 3.6k 2.0× 235 0.3× 322 0.5× 335 0.7× 165 10.4k

Countries citing papers authored by Claude P. Selitrennikoff

Since Specialization
Citations

This map shows the geographic impact of Claude P. Selitrennikoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claude P. Selitrennikoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claude P. Selitrennikoff more than expected).

Fields of papers citing papers by Claude P. Selitrennikoff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claude P. Selitrennikoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claude P. Selitrennikoff. The network helps show where Claude P. Selitrennikoff may publish in the future.

Co-authorship network of co-authors of Claude P. Selitrennikoff

This figure shows the co-authorship network connecting the top 25 collaborators of Claude P. Selitrennikoff. A scholar is included among the top collaborators of Claude P. Selitrennikoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claude P. Selitrennikoff. Claude P. Selitrennikoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bishop, Jeanette V., et al.. (2006). Novel Compounds Active against Leishmania major. Antimicrobial Agents and Chemotherapy. 50(2). 474–479. 31 indexed citations
2.
Patel, Champa, et al.. (2006). Construction of a Saccharomyces cerevisiae strain expressing the Leishmania major nucleoside hydrolase gene. International Journal of Antimicrobial Agents. 29(1). 103–107. 1 indexed citations
3.
Lucca, Anthony J. De, et al.. (2003). CAY-I, a novel antifungal compound from cayenne pepper. Medical Mycology. 41(1). 75–82. 4 indexed citations
4.
Clemons, Karl V., et al.. (2002). fos-1, a putative histidine kinase as a virulence factor for systemic aspergillosis. Medical Mycology. 40(3). 259–262. 60 indexed citations
5.
Lucca, Anthony J. De, John M. Bland, Melanie T. Cushion, et al.. (2002). CAY-1, a fungicidal saponin fromCapsicumsp. fruit. Medical Mycology. 40(2). 131–137. 37 indexed citations
6.
Selitrennikoff, Claude P., et al.. (2001). COS-1, a putative two-component histidine kinase ofCandida albicans, is anin vivovirulence factor. Medical Mycology. 39(1). 69–74. 35 indexed citations
7.
Pott, Gregory B., et al.. (2000). The Isolation of FOS-1, a Gene Encoding a Putative Two-Component Histidine Kinase from Aspergillus fumigatus. Fungal Genetics and Biology. 31(1). 55–67. 52 indexed citations
8.
Selitrennikoff, Claude P. & Gary R. Ostroff. (1999). Emerging therapeutic cell wall targets in fungal infections. 3(1). 53–72. 4 indexed citations
10.
Enderlin, Carol S., et al.. (1997). Inhibition of Neurospora crassa Growth by a Glucan Synthase-1 Antisense Construct. Current Microbiology. 34(5). 303–308. 20 indexed citations
11.
Enderlin, Carol S., et al.. (1994). A high throughput in vitro assay for fungal (1,3).BETA.-glucan synthase inhibitors.. The Journal of Antibiotics. 47(9). 1001–1009. 11 indexed citations
12.
Leslie, John F., et al.. (1993). Variability in antifungal proteins in the grains of maize, sorghum and wheat. Physiologia Plantarum. 88(2). 339–349. 1 indexed citations
13.
Selitrennikoff, Claude P.. (1992). Screening for Antifungal Drugs. Elsevier eBooks. 21. 189–217. 5 indexed citations
14.
Phelps, Patricia C., et al.. (1990). Cell wall assembly ofNeurospora crassa: Isolation and analysis of cell wall-less mutants. Current Microbiology. 21(4). 233–242. 8 indexed citations
15.
Jabri, Evelyn, et al.. (1989). (1–3)-β-Glucan synthesis ofNeurospora crassa. Current Microbiology. 19(3). 153–161. 16 indexed citations
16.
Selitrennikoff, Claude P., et al.. (1988). LY121019 inhibits Neurospora crassa growth and (1-3)-.BETA.-D-glucan synthase.. The Journal of Antibiotics. 41(5). 697–701. 28 indexed citations
17.
Selitrennikoff, Claude P., et al.. (1982). slime, the wall-less variant of Neurospora crassa: The loss of cell-wall assembly is not due to the loss of cell-wall primer or template. Experimental Mycology. 6(3). 203–209. 2 indexed citations
18.
Selitrennikoff, Claude P., et al.. (1982). Chitin synthetase activity is a dispensable function forNeurospora crassa protoplasts. Experimental Mycology. 6(1). 65–70. 9 indexed citations
19.
Selitrennikoff, Claude P., et al.. (1981). Formation and regeneration of protoplasts derived from a temperature-sensitiveosmotic strain ofNeurospora crassa. Experimental Mycology. 5(2). 155–161. 28 indexed citations
20.
Nelson, Robert E., Claude P. Selitrennikoff, & Richard W. Siegel. (1976). Developmental regulation of nicotinamide adenine dinucleotide (phosphate) glycohydrolase in Neurospora crassa. Developmental Biology. 50(1). 122–133. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026